Abstract: A therapeutic agent that includes a purified peptide bound to a cytotoxic moiety, the peptide being specifically reactive with human insulin autoantibodies and non-reactive with human insulin cell surface receptor, is disclosed.
Type:
Grant
Filed:
March 14, 1994
Date of Patent:
June 6, 1995
Assignee:
Joslin Diabetes Center, Inc.
Inventors:
George S. Eisenbarth, Luis Castano, Steven E. Shoelson
Abstract: The invention provides a novel method of effecting vasodilation in a warm-blooded animal in need of such treatment and involves administering to a warm-blooded animal an effective amount of a vasodilatory monoglyceride of the formula: ##STR1## wherein R is a straight or branched chain aliphatic hydrocarbyl substituent of 2-7 carbon atoms, preferably 3-5 carbon atoms, which is saturated or unsaturated, and which is substituted or unsubstituted with one or more substituents that do not interfere with vasodilatory activity.
Type:
Grant
Filed:
February 25, 1992
Date of Patent:
April 26, 1994
Assignees:
Joslin Diabetes Center, Dana-Farber Cancer Institute
Inventors:
Bruce M. Spiegelman, William O. Wilkison, Sven Bursell
Abstract: A method for determining the quantity of an antibody in a sample, the method having the steps of: (1) providing a labelled antigen to the antibody; (2) contacting the labelled antigen with the sample in solution to form a labelled antigen-antibody complex; (3) providing an agent for precipitating the complex; (4) mixing the solution containing the labelled antigen-antibody complex with the precipitating agent to produce a precipitate and a supernatant; the supernatant containing labelled antigen and the precipitate containing the labelled antigen-antibody complex and uncomplexed labelled antigen; and (5) measuring the quantity of label in the precipitate or the supernatant in a manner substantially independent of the amount of uncomplexed labelled antigen in the precipitate.
Abstract: Glucose sensing apparatus for use in biological fluids comprising an electrode and a voltage source connected to the electrode to cause a current to flow therethrough, in which the voltage applied to the electrode is varied in a sweep ranging from a first limit to a second limit and back toward the first limit, and the current at the electrode is integrated with respect to time during at least a portion of the voltage variation selected to produce a total charge sensitive to glucose concentration and relatively insensitive to other components in the fluid; alternatively the current is measured at a point in a specific region of the voltage variation.
Type:
Grant
Filed:
April 22, 1982
Date of Patent:
August 2, 1983
Assignee:
Joslin Diabetes Center, Inc.
Inventors:
Jose D. Giner, Harry Lerner, John S. Soeldner
Abstract: Glucose sensing apparatus for use in biological fluids comprising an electrode and a voltage source connected to the electrode to cause a current to flow therethrough, in which the voltage applied to the electrode is varied in a sweep ranging from a first limit to a second limit and back toward the first limit, and the current at the electrode is integrated with respect to time during at least a portion of the voltage variation selected to produce a total charge sensitive to glucose concentration and relatively insensitive to other components in the fluid; alternatively the current is measured at a point in a specific region of the voltage variation.
Type:
Grant
Filed:
June 2, 1980
Date of Patent:
July 20, 1982
Assignee:
Joslin Diabetes Center, Inc.
Inventors:
Harry Lerner, Jose D. Giner, John S. Soeldner